GSM1821523[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 4

Select item 2000709511.

Paired Breast Adenocarcinoma and Adjacent Normal tissue

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.

Organism:: Homo sapiens

Type:: Expression profiling by array

Platforms:: GPL13607 GPL4133
433 Samples

Download data: TXT

Series

Accession:: GSE70951

ID:: 200070951

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 2000709052.

Age and estrogen-dependent inflammation in breast adenocarcinoma and normal breast tissue [cohort_1]

(Submitter supplied) Chronic inflammation promotes breast tumor growth and invasion by accelerating angiogenesis and tissue remodeling in the tumor microenvironment. The relationship between inflammation and estrogen, which drives the growth of 70 percent of breast tumors, is complex. Low levels of estrogen exposure stimulate macrophages and other inflammatory cell populations, but very high levels are immune suppressive. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL4133
137 Samples

Download data: TXT

Series

Accession:: GSE70905

ID:: 200070905

Analyze with GEO2R

Select item 1000041333.

Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version)

(Submitter supplied) This multi-pack (4X44K) formatted microarray represents a compiled view of the human genome as it is understood today. The sequence information used to design this product was derived from a broad survey of well known sources such as RefSeq, Goldenpath, Ensembl, Unigene and others. The resulting view of the human genome covers 41K unique genes and transcripts which have been verified and optimized by alignment to the human genome assembly and by Agilent's Empirical Validation process. more...